Making sense of dual HER2-targeting in early breast cancer?
- PMID: 25224563
- DOI: 10.1093/jnci/dju259
Making sense of dual HER2-targeting in early breast cancer?
Comment on
-
Comparative effectiveness of neoadjuvant therapy for HER2-positive breast cancer: a network meta-analysis.J Natl Cancer Inst. 2014 Sep 15;106(9):dju203. doi: 10.1093/jnci/dju203. Print 2014 Sep. J Natl Cancer Inst. 2014. PMID: 25224562
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous